Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Centessa Pharmaceuticals plc | SVP Regulatory Affairs | Ordinary Shares | 62.6K | $507K | $8.10 | Feb 1, 2024 | Direct |
Centessa Pharmaceuticals plc | SVP Regulatory Affairs | Share Option (right to buy) | 75K | Feb 1, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CNTA | Centessa Pharmaceuticals plc | Feb 1, 2024 | 4 | -$68.2K | 4 | Feb 2, 2024 | SVP Regulatory Affairs |
CNTA | Centessa Pharmaceuticals plc | Sep 20, 2023 | 5 | -$72K | 4 | Sep 22, 2023 | SVP Regulatory Affairs |
CNTA | Centessa Pharmaceuticals plc | Jun 14, 2023 | 0 | $0 | 3 | Jun 23, 2023 | SVP Regulatory Affairs |